Protenus Recognized as One of the Best Places to Work in Healthcare in 2019

CHICAGO, May 14, 2019 /PRNewswire/ — Protenus has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare. The complete list of this year’s winners, in alphabetical order, is available here. Modern Healthcare will publish a special supplement featuring ranked lists of all the winners along with the Sept. 30, 2019, issue.

The team at Protenus focuses on providing an exceptional experience for its customers and this naturally translates to the company’s work culture. Protenus offers a holistic approach to care for each individual by providing transparent, market-based compensation, employee stock options, healthcare premiums covered at 90 percent for employees, unlimited paid time off, flexible work hours and a casual, collaborative environment. These benefits are deeply rooted in Protenus’ values and are an important part of the company’s strategy to attract and retain great people.

“At Protenus, we are advancing the science of healthcare by bringing together creative and skilled individuals who are passionate about the security and usability of health data,” said Megan Emhoff, vice president of people operations for Protenus. “When we welcome a new employee to the team, we commit to investing in the whole person. We do this by providing opportunities for people to grow and thrive professionally while providing robust benefits and promoting a meaningful quality of life. We’re humbled to be recognized by Modern Healthcare and to be included alongside such a great group of companies.”

The Modern Healthcare awards program identifies and recognizes outstanding employers in the healthcare industry nationwide. Modern Healthcare partners with the Best Companies Group on the assessment process, which includes an extensive employee survey.

Protenus will be honored at the 2019 Best Places to Work in Healthcare awards gala on Thursday, Sept. 26, 2019, at the Renaissance Dallas. Information on the award and dinner program is available here.

About Protenus

The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. These analytics provide healthcare leaders full insight into how health data is being used and alerting privacy, security and compliance teams to inappropriate activity. Protenus helps our partner hospitals make decisions about how to better protect their data, their patients and their institutions. This year, Protenus was named the 2019 KLAS Category Leader in Patient Privacy Monitoring. Protenus was also named one of The 2019 Best Places to Work in Healthcare by Modern Healthcare and one of the Best Places to Work in Baltimore by the Baltimore Business Journal. Learn more at Protenus.com and follow us on Twitter @Protenus.

Media Contact:
Kira Caban
Director of Strategic Communications
kira@protenus.com

View original content:http://www.prnewswire.com/news-releases/protenus-recognized-as-one-of-the-best-places-to-work-in-healthcare-in-2019-300849499.html

SOURCE Protenus

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

3 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

6 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

6 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

6 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

6 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

6 hours ago